Products & ReviewClinical Diagnostics

Shine i1000 Fully Automatic CLIA Analyzer

The smallest fully automated chemiluminescence analyzer, with large capacity, integrated computer and touch screen. 

The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our  Product Directory.

Reviews

Average Rating 5.0

|1Scientists have reviewed this product

Ease of Use
After Sales Service
Value for Money
Write your own review

Great equipment

 

Average Rating 5.0

Application Area:

Application support

Worth the money. Compact CLIA analyzer in bench top version with big panel strength.

Review Date: 31 Jul 2022 | Fapon Group

Excellent performance

  • Throughput: up to 200 tests per hour, integrated computer and touch screen
  • Up to 120 test per hour
  • First results in ≤ 12 min

Compact and convenient

  • Footprint 0.19m2, patented technology for highly integrated and simplified design
  • Batch/random/STAT mode available
  • Integrated control panel with machine, all consumable loading in real-time

Innovative design

  • Incubation, washing and detection all-in-one, detection efficiency improved
  • Using automatic intelligent control technology, low instrument failure rate
  • 100+ patented technologies, 100% self-developed

Compatible system

  • Compatible with AE/AP/HRP/ABEI CLIA assay protocol
  • Compatible with immunological reagents and instruments with different parameters and reaction modes

Fapon drives innovation in the U.S. clinical market

Learn about Fapon's key products tailored for the U.S. in vitro diagnostics market and its approach to meeting local needs. Narayan Krishnaswami, Regional Marketing Director, and Nick Guan, Vice President of Molecular Diagnostics R&D, discuss the company's clinical diagnostics strategy in the U.S. and highlight the contributions of Fapon's research centers in San Francisco and Boston.

Explore Fapon's future plans for expanding and strengthening its presence in the U.S., including innovations in Alzheimer's disease diagnostics and upcoming antibodies for vitamin D testing. Discover how Fapon is committed to catering to the unique demands of the U.S. market through continuous innovation and strategic localization. Plus, hear about Fapon's development plan for its highlighted product of the year, the Teloscript reverse transcriptase, and about the company's focus on infectious diseases such as influenza, COVID-19, syphilis, and HIV.
This video was filmed at ADLM 2024.


Product Overview

Links